CTLA4 DNA methylation is associated with CTLA-4 expression and predicts response to immunotherapy in head and neck squamous cell carcinoma.

MLA

Hoffmann, Friederike, et al. “CTLA4 DNA Methylation Is Associated with CTLA-4 Expression and Predicts Response to Immunotherapy in Head and Neck Squamous Cell Carcinoma.” Clinical Epigenetics, vol. 15, no. 1, July 2023, p. 112. EBSCOhost, https://doi.org/10.1186/s13148-023-01525-6.

APA

Hoffmann, F., Franzen, A., de Vos, L., Wuest, L., Kulcsár, Z., Fietz, S., Maas, A. P., Hollick, S., Diop, M. Y., Gabrielpillai, J., Vogt, T., Kuster, P., Zarbl, R., Dietrich, J., Kristiansen, G., Brossart, P., Landsberg, J., Strieth, S., & Dietrich, D. (2023). CTLA4 DNA methylation is associated with CTLA-4 expression and predicts response to immunotherapy in head and neck squamous cell carcinoma. Clinical Epigenetics, 15(1), 112. https://doi.org/10.1186/s13148-023-01525-6

Chicago

Hoffmann, Friederike, Alina Franzen, Luka de Vos, Lennert Wuest, Zsófi Kulcsár, Simon Fietz, Alexander Philippe Maas, et al. 2023. “CTLA4 DNA Methylation Is Associated with CTLA-4 Expression and Predicts Response to Immunotherapy in Head and Neck Squamous Cell Carcinoma.” Clinical Epigenetics 15 (1): 112. doi:10.1186/s13148-023-01525-6.